Skip to main content
. 2023 Jun 28;14:1211730. doi: 10.3389/fimmu.2023.1211730

Figure 3.

Figure 3

Silencing or inhibiting AIM2 in macrophages reverses IL1β production induced by tumor CM. (A) IL-1β levels from control, LPS or PMA Primed THP-1 cells transfected with AIM2 siRNAs or scrambled siRNAs (siRNA Control) and treated with A549 CM. (B, C) IL-1β levels and inflammasome activation in LPS and PMA primed THP-1 cells pre-treated with A151 for 1h prior to treatment with A549 CM. Graph shows the quantification of immunoblots using Image J (fold change vs Actin) (D,E) IL-1β levels in LPS-primed WT and AIM2-/- or Caspase1/11-/- BMDM treated with mouse TRAMP-C2 CM or Poly(dA:dT). Data represents mean ± SEM of at least 3 independent experiments. **p<0.01; ***p<0.001, **** p<0.0001. # p<0.05; ##p<0.01; ###p<0.001; ####p<0.0001.